Latest Commercialisation News

Carnegie Clean Energy launches a $3 million Share Purchase Plan at a 20% discount to fund its pioneering 6 MW CETO wave energy project in Spain and expand its global footprint.

Iondrive Limited has won a $3.9 million government grant to advance its innovative urban mining technology, accelerating the construction of a pilot plant focused on critical minerals recovery from lithium-ion batteries.

Hazer Group has filed patents for a breakthrough graphite purification process that could unlock access to the lucrative battery materials market amid tightening global supply. This innovation positions Hazer to meet surging demand for high-purity graphite essential for lithium-ion batteries.

Imagion Biosystems has completed the first tranche of its $3.5 million capital raising, issuing 45 million new shares to strengthen its financial position ahead of a key shareholder vote.

Livium Ltd and Mineral Resources Ltd have formalised a 50 – 50 joint venture to commercialise the innovative LieNA® lithium processing technology, aiming to license it globally despite current market headwinds.

Tamboran Resources’ Shenandoah South 2H sidetrack well has achieved a record 90-day average gas flow rate in the Beetaloo Basin, maintaining stable production and advancing the company’s multi-well drilling campaign.

Green360 Technologies has successfully raised A$4 million through a share placement to fund the commercialisation and scaling of its innovative low-carbon cement technology, supported by institutional investors and strengthened leadership.

Invex Therapeutics reports a significantly reduced net loss for FY25, driven by lower R&D costs after closing its Phase III trial, while advancing promising pre-clinical Alzheimer’s research through a collaboration with Tessara Therapeutics.

FBR Limited has raised A$2 million through a share placement and purchase plan, complementing a $20 million subscription facility, to fund new robotic products, strategic partnerships, and debt repayment.

Neometals has agreed to sell its 50% stake in the lithium-ion battery recycling joint venture Primobius to SMS Group for €5 million upfront plus future royalties, marking a strategic pivot away from capital-intensive projects.

Papyrus Australia appoints Daniel Schmidt as CEO to lead its transition from R&D to commercial operations, alongside a strategic restructure to support growth.

Neuren Pharmaceuticals reports a 16% rise in Q2 2025 royalties driven by Acadia’s DAYBUE sales growth and expanding patient base in the US. Full-year sales guidance remains strong with European market entry on the horizon.